Skip to search formSkip to main contentSkip to account menu

CT 2584

Known as: CT-2584, CT2584, CT2584 HMS 
A substance that is being studied in the treatment of cancer. It may prevent the growth of blood vessels from surrounding tissue into a solid tumor.
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Apra

Broader (1)

Xanthines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
CT-2584 (Cell Therapeutics).
CT-2584, an anticancer agent that inhibits phospholipid signaling, is under development by Cell Therapeutics Inc (CTI) as a… 
2001
2001
CT-2584 (Cell Therapeutics).
1999
1999
Development and validation of a sensitive solid-phase extraction and high-performance liquid chromatography assay for the novel antitumour agent CT2584 in human plasma.
Highly Cited
1997
Highly Cited
1997
Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses.
1997
1997
Effect of a xanthine analog on human hepatocellular carcinoma cells (Alexander) in culture and in xenografts in SCID mice
Hepatocellular carcinoma (HCC) frequently overexpresses the MDR1 gene and is resistant to drugs transported by the multidrug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)